Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology’s Annual Scientific Session.
Living near green spaces linked to higher bone density and lower osteoporosis risk
Living in leafy areas near gardens, parks, and green spaces, may boost bone density and lower the risk of osteoporosis, finds research published online in
March 6, 2024